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Abstract
Purpose To validate the German version of the spinal
stenosis measure (SSM), a disease-specific questionnaire
assessing symptom severity, physical function, and satis-
faction with treatment in patients with lumbar spinal
stenosis.
Methods After translation, cross-cultural adaptation, and
pilot testing, we assessed internal consistency, test–retest
reliability, construct validity, and responsiveness of the
SSM subscales. Data from a large Swiss multi-center
prospective cohort study were used. Reference scales for
the assessment of construct validity and responsiveness
were the numeric rating scale, pain thermometer, and the
Roland Morris Disability Questionnaire.
Results One hundred and eight consecutive patients were
included in this validation study, recruited from five dif-
ferent centers. Cronbach’s alpha was above 0.8 for all three
subscales of the SSM. The objectivity of the SSM was
assessed using a partial credit approach. The model showed
a good global fit to the data. Of the 108 patients 78 par-
ticipated in the test–retest procedure. The ICC values were
above 0.8 for all three subscales of the SSM. Correlations
with reference scales were above 0.7 for the symptom and
function subscales. For satisfaction subscale, it was 0.66 or
above. Clinically meaningful changes of the reference
scales over time were associated with significantly more
improvement in all three SSM subscales (p \ 0.001).
Conclusion The proposed version of the SSM showed
very good measurement properties and can be considered
validated for use in the German language.
Keywords Spinal stenosis  Questionnaire  Cross-
cultural  Validation study  Rasch analysis  German
language
Introduction
Degenerative lumbar spinal stenosis is a common disease
in elderly patients defined by diminished space for the
neural and vascular elements in the central canal of the
lumbar spine secondary to degenerative changes in the
facet joints, ligaments, vertebrae, and intervertebral discs
[1, 2]. When symptomatic, patients complain of pain in the
buttocks and lower extremities with or without low back
pain provoked by walking or extended standing that is
relieved by rest and forward bending.
The Spinal Stenosis Measure (SSM) is a disease-specific
questionnaire assessing symptom severity, physical func-
tion, and satisfaction with treatment of lumbar spinal ste-
nosis [3]. The questionnaire was developed and first
validated by Stucki et al. [3] and has been used in various
studies investigating treatment of spinal stenosis. The SSM
is recognized as a useful tool to quantify, in addition to
pain and disability, the specific neuroischemic character-
istics and adverse effects on walking capacity associated
with degenerative lumbar spinal stenosis [4, 5]. To date,
the SSM exists in an English, Slovenian [6], and
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Norwegian version [7], but a German version has not been
validated.
The aim of this study was to translate and cross-cul-
turally adapt the English SSM into German, and to test the
German version for psychometric properties in terms of its
reliability and validity.
Methods
This research is part of a multi-center prospective cohort
study in Switzerland investigating the prognosis and
treatment of patients with lumbar spinal stenosis [8]. The
study was approved by the local ethical committee and
conducted in accordance with the Declaration of Helsinki
[9]. All patients received written and oral information
about the study and gave their written consent to
participate.
Eligibility criteria and patients
Patients were recruited during consultations in the Rheu-
matology and Spine Surgery Units in five hospitals located
in the Cantons of Zurich and Lucerne, Switzerland.
Inclusion criteria were: (1) age C50 years; (2) uni- or
bilateral neurogenic claudication (defined by pain in the
buttocks and/or lower extremities provoked by walking or
extended standing and relieved by rest and/or bending
forward); (3) verified spinal stenosis (central or lateral
verified by computer tomography or magnetic resonance
imaging); (4) anticipated life expectancy more than 1 year;
(5) able to give informed consent; (6) available for follow-
up; and (7) able to complete questionnaires in German.
Exclusion criteria were: red flags (e.g., cauda equina
syndrome, infection), current vertebral fracture, significant
deformity ([15 lumbar scoliosis), or clinically relevant
peripheral arterial disease (confirmed by a vascular
specialist).
For the validation study, all consecutive patients ful-
filling the following criteria were included: complete data
at baseline and 6 months follow-up. Patients were invited
to participate in a test–retest procedure at 6 months for the
three SSM subscales.
Questionnaire
The SSM (also known as the Spinal Stenosis Measure,
Zurich Claudication Questionnaire, or Brigham Spinal
Stenosis Questionnaire) is a reproducible, valid, internally
consistent, self-administered questionnaire that is respon-
sive to clinical change and validated in English [3, 10] and
other languages [6, 7]. The three subscales are the SSM
symptom severity scale (SSM symptom, 7 items), the SSM
physical function scale (SSM function, 5 items), and the
SSM satisfaction scale (6 items). The SSM symptom scale
consists of a pain subdomain (3 items) and a neuroischemic
subdomain (4 items). Each item is rated on a Likert scale—
the SSM symptom: no (1) to very severe symptoms (5);
SSM function: yes, comfortably (1) to no, could not per-
form (5); SSM satisfaction: very satisfied (1) to very dis-
satisfied (4).
The unweighted mean was calculated for all subscales
of all answered questions if fewer than two items were
missing in the SSM function and SSM satisfaction, and
fewer than three items were missing in the SSM
symptom.
Translation and cross-cultural adaptation
A sequential forward and backward translation approach
was used following international guidelines [11]. Two
professional translators independently translated the Eng-
lish language version of the SSM into German. In a con-
sensus meeting with the translators, two rheumatologists
and a methodologist agreed on the first German versions
for these formats. We then pilot tested these versions with
five patients recruited from a rheumatology outpatient
clinic to identify difficulties in understanding. When the
translation team considered more than one possible ver-
sion, the different versions were tested. A third professional
English translator, unaware of the original English SSM,
performed a back translation of the German SSM into the
source language (English). The back translation was
compared by the two rheumatologists and a methodologist
with the English SSM to check for and solve conceptual
discrepancies.
Procedure and measurements
All patients participating in the prospective cohort study
completed baseline information about socio-demographic
characteristics, symptoms, clinical examination, and treat-
ments for lumbar spinal stenosis received within the last
6 months. The SSM and the following information were
collected: pain intensity (numeric rating scale, NRS [12,
13], pain thermometer [14]); functional disability [German
version of the Roland Morris Disability Questionnaire
(RMQ)] [15–17]; and psychosocial factors [German ver-
sion of the Fear Avoidance Beliefs Questionnaire of
physical activity (FABQ-P)] [18], Pain Self-Efficacy
Questionnaire, German FESS [19]. Unless otherwise sta-
ted, data at 6 months or change from baseline to 6 months
were used for the validation, as we considered these
observations more stable and reliable than those collected
at baseline, when many patients were at the beginning of a
new therapy.
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Sample size calculation
As recommended by Terwee et al. [20], we aimed to
include a minimum of 50 patients for assessing construct
validity, reproducibility, and floor or ceiling effects; and a
minimum of 100 patients for assessing internal
consistency.
Descriptive statistics
For continuous data, median and interquartile ranges are
given. We examined the distribution of SSM subscales for
potential floor and ceiling effects at baseline and at
6 months visually, using histograms.
Internal consistency
Intercorrelation of the items in the subscales was assessed
by using Cronbach’s alpha. We evaluated the objectivity of
the scale by using a more sophisticated approach, the
partial credit model (PCM), to address responses recorded
in ordered categories. The PCM is special case of the
Rasch models [21] which quantifies the patient-specific
influence on item responses ([22], p. 3). We assessed the
global goodness of fit with the Andersen likelihood ratio
test [23]. Item fit was addressed with a Chi-squared test.
We examined the SSM symptom, function, and satisfac-
tion, and the two subdomains of pain and neuroischemic
pain for differential item functioning (DIF) with respect to
the grouping variables of age, gender, and level of educa-
tion. We estimated the threshold parameters for the latent
dimensions of the answer categories within each item to
determine whether they are ordered increasingly.
Test–retest reliability
Reproducibility (test–retest) concerns the degree to which
repeated measurements in stable persons provide similar
answers [20]. All patients who completed 6 months follow-
up were invited to participate in the test–retest procedure.
Patients who completed a retest questionnaire between 3
and 7 days after the 6 months follow-up were included in
this analysis.
Test–retest reliability was established by using the
Spearman correlation coefficient and the intraclass corre-
lation coefficient (ICC) [24]. Bland and Altman plots were
used for graphical representation of the repeated measures.
Construct validity
Construct validity refers to the extent to which scores on
the SSM relate to other widely accepted measures in
theoretically related or unrelated concepts [20]. We
hypothesized a priori that variables from validated tools
representing the same dimension of the disease would be
more correlated with SSM subscales than variables repre-
senting different dimensions. Hence, we expected a strong
correlation between the SSM symptom scale and pain
(NRS and feeling thermometer) and between SSM function
and disability (RMQ). For the SSM satisfaction scale, we
hypothesized an inverse association at 6 months with dis-
ability (RMQ) and pain after treatment (NRS and feeling
thermometer). In contrast, we expected a low to moderate
correlation between the SSM subscales and psychosocial
variables (FABQ-P, FESS). For the assessment of construct
validity, Spearman correlation coefficients were used.
Responsiveness
The ability of the SSM to detect clinically important
changes over time (responsiveness) was assessed compar-
ing the SSM difference baseline to 6 months follow-up to a
clinically meaningful important difference (CMID) in
RMQ and NRS, respectively, by using the Wilcoxon test
[20, 25]. A CMID in RMQ and NRS is achieved if a 30 %
reduction is observed [17]. Patients were split into two
groups: one with CMID, and without CMID in NRS at
6 months, and they were compared with respect to changes
in the SSM symptom scale. The same comparison was
made for CMID in RMQ and changes in the SSM function
scale.
For the SSM satisfaction scale at 6 months, we
hypothesized an association with a decrease in disability
(RMQ) and pain after treatment (NRS). Patients with and
without CMID in RMQ or NRS were compared with
respect to SSM satisfaction by using the Wilcoxon test.
We expected the changes in the SSM symptom, func-
tion, and satisfaction scales to be weakly correlated with
the longitudinal changes in the psychosocial variables (i.e.,
FABQ-P, FESS). Comparisons of the SSM subscales and
the psychological variables were performed with Spearman
correlation coefficients.
Statistical analysis
Correlation coefficients and the ICC are reported includ-
ing 95 percent confidence interval (95 % CI). The 95 %
CI for Spearman correlation coefficient were derived with
bootstrapping based on 1,000 replicates. Strength of
agreement for the correlation coefficient and the ICC was
expressed as follows: strong (C0.70), moderate ([0.5–
\0.7), weak (B0.5) [20]. For analysis, the statistical
software R was used [26]. The PCM was fitted with the
eRm package [27].
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Results
Patients and measurements
Of the 372 patients enrolled in the study as of May 2013,
231 had completed a 6 months follow-up assessment. For
this validation study, 108 patients (47 %) with lumbar
spinal stenosis fulfilled the inclusion criteria (baseline
characteristics Table 1). The German version of the SSM
(‘‘Appendix 1’’) was well understood. Nearly all patients
answered a complete set of SSM questions. In total only
four questions remained unanswered (once each of the
following items: SSM symptom and function item 2, 4, 9
and SSM satisfaction item 3). Visual inspection of the
histograms of the SSM revealed no floor or ceiling effects
in any subscale at baseline and a potential floor effect of
the function scale at 6 months (‘‘Appendix 2’’). When this
result was compared to the histogram of the RMQ at
6 months, we found the same floor effect.
Internal consistency
The results are summarized in Table 2. Cronbach’s alpha at
6 months for the SSM symptom was 0.83, for the SSM
Table 1 Baseline characteristics (n = 108)
Variable Median IQR
Gender Males: 60 (56 %)
Age (year) Median: 73.5 IQR:
68.0–79.0
Treatment before inclusion in the study
% Surgery Yes: 4 (4 %)
% Epidural injections of
steroids
Yes: 30 (28 %)
Nationality Swiss: 102
(94 %)
Other: 6 (6 %)
RMQ (0–24) Median: 12.5 IQR: 7.0–16.0
FABQ-physical (0–24) Median: 16.0 IQR: 9.3–21.0
FESS (10–60) Median: 29.0 IQR:
20.0–40.0
Pain thermometer (0–100) Median: 63.0 IQR:
48.5–80.0
NRS (0–10) Median: 6.0 IQR: 4.8–8.0
Mean and interquartile range for continuous variables, number and
percent for categorical variables
RMQ Roland Morris Questionnaire (score 0–24), NRS numeric rating
scale (score 0–10), FABQ-P fear avoidance physical function sub-
scale (score 0–24), FESS pain self-efficacy questionnaire (score
10–60)
Table 2 Measurement
properties of the SSM subscales
with 95 % confidence interval
(95 % CI)
CMID clinically meaningful
change, RMQ Roland Morris
Questionnaire (score 0–24),
NRS numeric rating scale (score
0–10), FABQ-P fear avoidance
physical function subscale
(score 0–24), FESS pain self-
efficacy questionnaire (score
10–60), mo. months, basel.
baseline
Patient Analysis SSM subscales
Symptoms 7 items Function 5 items Satisfaction 6 items
n = 108 Internal consistency
Cronbach’s alpha
0.83 0.86 0.87
n = 108 PCM, global fit (p value) 0.23 0.42 0.10
n = 78 Test–retest reliability
Spearman correlation
0.86 (0.75; 0.92) 0.82 (0.70; 0.91) 0.87 (0.77; 0.94)
n = 78 Test–retest reliability ICC 0.87 (0.81; 0.92) 0.81 (0.71; 0.87) 0.90 (0.84; 0.93)
n = 108 NRS Spearman correlation 0.73 (0.60; 0.82) 0.63 (0.49; 0.74) 0.73 (0.59; 0.84)
n = 108 Feel thermometer
Spearman correlation
0.73 (0.60; 0.83) 0.63 (0.48; 0.76) 0.71 (0.56; 0.82)
n = 108 RMQ Spearman correlation 0.63 (0.47; 0.75) 0.70 (0.56; 0.80) 0.66 (0.51; 0.78)
n = 108 FESS Spearman correlation 0.53 (0.36; 0.66) 0.59 (0.43; 0.73) 0.61 0.45; 0.75)
n = 108 FABQ-P Spearman
correlation
0.40 (0.20; 0.56) 0.51 (0.33; 0.66) 0.49 (0.32; 0.62)
n = 108 Floor or ceiling effect
Baseline No No –
6 months No Yes (floor) No
n = 108 CMID RMQ difference
(Wilcoxon test)
D basel. - 6 mo. D basel. - 6 mo. 6 mo.
0.71 (p \ 0.001) 0.80 (p \ 0.001) 0.67 (p \ 0.001)
n = 108 CMID NRS difference
(Wilcoxon test)
D basel. - 6 mo. D basel. - 6 mo. 6 mo.
0.86 (p \ 0.001) 0.60 (p \ 0.001) 0.67 (p \ 0.001)
n = 108 FESS Spearman correlation 0.35 (0.16; 0.51) 0.52 (0.36; 0.66) 0.32 (0.15; 0.48)
n = 108 FABQ-P Spearman
correlation
0.28 (0.11; 0.44) 0.39 (0.19; 0.57) 0.25 (0.06; 0.42)
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function 0.86, and for the SSM satisfaction 0.87. For the
subdomain pain, the Cronbach’s alpha was 0.90 and for the
neuroischemic subdomain it was 0.69.
The PCM showed a good global fit of the data in all its
subscales (p values ranging from 0.06 to 0.42). When we
addressed the item fit of the scales, we found items 5 and 7
(‘‘Appendix 1’’) of the SSM symptom scale to be prob-
lematic (p \ 0.05 in Chi-squared test). We found no more
significant deviations from item fit expectations in the other
scales (Table 3). Grouping variables for potential DIF were
age, gender, and level of education. We found no DIF in
any of the scales, except for gender DIF (p = 0.02, like-
lihood ratio test) in the SSM function (Table 3). The
thresholds of the latent dimensions of the response cate-
gories in all scales were examined and displayed graphi-
cally. All thresholds were ordered, indicating good
response patterns in the items. Figure 1 shows the category
characteristic curves for the three items of the pain sub-
domain as an example.
Test–retest reliability
Seventy-eight patients participated in the test–retest pro-
cedure (characteristics in ‘‘Appendix 3’’). Correlation
analysis (Spearman correlation coefficient) for the SSM
symptom, function, and satisfaction scale was 0.86, 0.82,
and 0.87 respectively (Table 2). The correlation coefficient
for the subdomains pain and neuroischemic was 0.78 and
0.88, respectively. The intraclass correlation coefficient in
the ICC analysis for the SSM symptom, function, and
satisfaction scale was 0.87, 0.81, and 0.90, respectively.
Bland and Altman plots were examined for visual repre-
sentation of the relationships (‘‘Appendix 4’’).
Construct validity
We found a strong correlation between the SSM symptom
and pain scale (NRS and pain thermometer: Spearman
correlation 0.73, Table 2). A strong correlation was found
between the SSM function scale and RMQ (Spearman
correlation 0.70). The correlation was moderate to strong
between the SSM satisfaction scale and RMQ (0.66), NRS
(0.73), and pain thermometer (0.71). As expected, the
correlations between the SSM subscales and the psycho-
logical measures were weak to moderate (FESS and
FABQ-physical below 0.60).
Responsiveness
Out of 108 patients, 52 (48 %) had a CMID in NRS and 45
(42 %) in RMQ over 6 months. The improvement in SSM
symptom scale was significantly larger in patients with
CMID in NRS compared to patients without CMID in the
NRS (mean difference of change = 0.86, p \ 0.001). We
found similar results for SSM function scale and RMQ
(mean difference of change = 0.80, p \ 0.001). For the
satisfaction subscale, there was again a significant differ-
ence between both CMID in NRS and RMQ.
As hypothesized, we found correlations below 0.5
between the psychosocial variables (FESS, FABQ-physical).
Discussion
In patients with lumbar spinal stenosis, the German version
of the SSM is a well-understood and reproducible tool to
measure symptoms and disability. The test results were
reproducible, and the subscales showed a high internal
consistency and a good responsiveness. Reliability in the
partial credit analysis was good because of good global,
item, and person fit. Age, gender, and education did not
influence the response to items. The global SSM symptom
score, however, was less consistent.
Comparison with the literature
Internal consistency, test–retest reliability, and respon-
siveness for the German version of the SSM were similar to
Table 3 Results of fitting the
partial credit model (PCM) to
the SSM data
* Andersen likelihood ratio test
** No appropriate response
patterns to conduct the analysis
SSM
symptom
Pain
subdomain
Neuroischemic
subdomain
SSM function SSM
satisfaction
Global fit LR* test
(p value)
0.23 ** 0.06 0.42 0.10
Item fit problems (v2 test,
p value \0.05)
Item 5, 7 No
problematic
item fit
No problematic
item fit
No
problematic
item fit
No
problematic
item fit
DIF (LR test, p value)
Age [70 years 0.92 0.71 0.94 0.07 0.20
Gender 0.27 0.08 0.22 0.02 0.81
Education 0.90 0.64 0.84 0.44 0.97
Ordered thresholds Yes Yes Yes Yes Yes
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other validation studies [3, 7]. We believe this is the first
study that used the PCM and item response theory together
with classical approaches to evaluate all three subscales of
the SSM. Comer et al. [28] used a Rasch/partial credit
analysis alone. While they found that the SSM function
performed well as unidimensional scale, they found the
SSM symptom scale to be multidimensional. Stucki et al.
[3] described two subdomains (neuroischemic and pain) in
the original validation and found a lower internal consis-
tency for the neuroischemic subdomain compared to the
pain subdomain (Cronbach’s alpha 0.63 vs. 0.73). Simi-
larly, we found a good global, item, and person fit for the
SSM function scale and the greatest variance in several
items of the SSM symptom scale. When the pain and the
neuroischemic subdomain were analyzed separately, we
found a good item and personal fit for the pain subdomain.
For the neuroischemic subdomain, we found no deviations
from the PCM assumptions indicating the objectivity of the
measure.
Strength and limitations
We followed current guidelines for the cross-cultural
validation, complied with sample size requirements, and
used the PCM in addition to conventional statistical
methods to investigate the reliability of the SSM. How-
ever, a potential limitation might be that by choosing
6 months follow-up data for the validation procedure, a
potential floor effect in the SSM function scale was
observed. Further, the wording of questions was adapted
for a Swiss German population. Therefore, additional
language adaptation for some areas in Germany might be
warranted.
Implication for research
The SSM can be used in research to assess pain, phys-
ical function, and satisfaction in patients with lumbar
spinal stenosis. We suggest reporting the subdomains of
the SSM symptom scale separately. This will allow cli-
nicians and researchers to see the differences in the
neuroischemic and pain symptoms. Research should aim
to increase knowledge about the neuroischemic compo-
nent in patients with lumbar spinal stenosis. Further, the
correlation between findings in imaging studies and
symptoms reported needs to be investigated. Recently, a
study showed that less than two out of ten patients with
severe spinal stenosis in imaging studies report symp-
toms [29].
Implication for clinical practice
The German version of the SSM is an easy to use, well-
understood self-reported questionnaire that assesses
symptoms, function, and satisfaction in patients with
lumbar spinal stenosis.
Conclusion
The proposed version of the SSM showed very good
measurement properties and can be considered validated
for use in the German language. We suggest reporting the
subdomains for pain and neuroischemic symptoms sepa-
rately. This is consistent with the findings in validation
studies of the English version.
Fig. 1 Category characteristic
curves for the three items in
pain subdomain of the SSM
symptom scale. The thresholds
of the answer categories for all
three items are ordered as the
lines intersect increasingly from
answer category 1 to category 5
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Appendices
Appendix 1: German version of the spinal stenosis
measure (SSM)
(a) SSM symptom subscale:
Beantworten Sie bitte folgende Fragen bezogen auf den
letzten Monat:
1. Wie wu¨rden Sie die Schmerzen beschreiben, die Sie
durchschnittlich im Ru¨cken, im Gesa¨ss und ausstrahlend in
die Beine verspu¨rt haben?
keine Schmerzen
leichte Schmerzen
ma¨ssige Schmerzen
starke Schmerzen
sehr starke Schmerzen
2. Wie oft hatten Sie Schmerzen im Ru¨cken, im Gesa¨ss
oder in den Beinen?
weniger als einmal pro Woche
mindestens einmal pro Woche
ta¨glich, meistens mehrere Minuten lang
ta¨glich, u¨ber die meiste Zeit
ta¨glich, ununterbrochen
3. Wie wu¨rden Sie die Schmerzen in Ihrem Ru¨cken oder
im Gesa¨ss beschreiben?
keine Schmerzen
leichte Schmerzen
ma¨ssige Schmerzen
starke Schmerzen
sehr starke Schmerzen
4. Wie wu¨rden Sie die Schmerzen in Ihren Beinen und
Fu¨ssen beschreiben?
keine Schmerzen
leichte Schmerzen
ma¨ssige Schmerzen
starke Schmerzen
sehr starke Schmerzen
5. Hatten Sie Taubheitsgefu¨hle oder Ameisenkribbeln in
Ihren Beinen oder Fu¨ssen?
gar nicht
leicht
ma¨ssig
stark
sehr stark
6. Stellten Sie eine Muskelschwa¨che in Ihren Beinen
oder Fu¨ssen fest?
gar nicht
leicht
ma¨ssig
stark
sehr stark
7. Litten Sie unter Gleichgewichtssto¨rungen?
Nein, ich hatte keine Gleichgewichtssto¨rungen
Ja, zeitweise hatte ich Gleichgewichtssto¨rungen oder das
Gefu¨hl, keinen sicheren Stand zu haben
Ja, ich habe oft Gleichgewichtssto¨rungen oder das Ge-
fu¨hl, keinen sicheren Stand zu haben
(b) SSM function scale subscale:
8. Wie weit konnten Sie am Stu¨ck laufen?
Mehr als 3 km
Mehr als 200 m aber weniger als 3 km
Mehr als 15 m, aber weniger als 200 m
Weniger als 15 m
9. Sind Sie zum Vergnu¨gen draussen spazieren
gegangen?
ja, problemlos
ja, aber teilweise mit Schmerzen
ja, aber immer mit Schmerzen
nein
10. Haben Sie Lebensmittel- oder andere Einka¨ufe er-
ledigen ko¨nnen? Ko¨nnten Sie Lebensmittel- oder andere
Einka¨ufe erledigen, wenn Sie mu¨ssten?
ja, problemlos
ja, aber teilweise mit Schmerzen
ja, aber immer mit Schmerzen
nein
11. Konnten Sie in den Wohnra¨umen Ihres Hauses oder
Ihrer Wohnung umher laufen?
ja, problemlos
ja, aber teilweise mit Schmerzen
ja, aber immer mit Schmerzen
nein
12. Konnten Sie von Ihrem Schlafzimmer ins Bad
laufen?
ja, problemlos
ja, aber teilweise mit Schmerzen
ja, aber immer mit Schmerzen
nein
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(c) SSM satisfaction subscale:
In den folgenden Fragen werden Sie nach Ihrer Zu-
friedenheit mit der Therapie gefragt. Therapie kann bede-
uten dass Sie operiert wurden, Medikamente erhielten oder
eine Physiotherapie verordnet bekamen. Keine Therapie
kann medizinisch gesehen auch eine Therapie sein. Bitte
beantworten Sie die Fragen in jedem Falle, auch wenn Sie
keine Therapie erhielten. Beantworten Sie bitte folgende
Fragen bezogen auf den letzten Monat.
Wie zufrieden sind Sie mit …
1. …dem Gesamtergebnis Ihrer Operation/der Therapie?
Sehr zufrieden
Einigermassen zufrieden
Etwas unzufrieden
Sehr unzufrieden
2. …dem Ru¨ckgang der Schmerzen nach der Operation/
der Therapie?
Sehr zufrieden
Einigermassen zufrieden
Etwas unzufrieden
Sehr unzufrieden
3. …Ihrem Gehvermo¨gen nach der Operation/der
Therapie
Sehr zufrieden
Einigermassen zufrieden
Etwas unzufrieden
Sehr unzufrieden
4. …Ihrer Fa¨higkeit, Haus- und Gartenarbeiten sowie
Ta¨tigkeiten am Arbeitsplatz zu verrichten?
Sehr zufrieden
Einigermassen zufrieden
Etwas unzufrieden
Sehr unzufrieden
5. …Ihrer Kraft in den Oberschenkeln, Beinen und
Fu¨ssen?
Sehr zufrieden
Einigermassen zufrieden
Etwas unzufrieden
Sehr unzufrieden
6. …Ihrem Gleichgewichtssinn oder der Stabilita¨t in
Ihren Fu¨ssen?
Sehr zufrieden
Einigermassen zufrieden
Etwas unzufrieden
Sehr unzufrieden
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Appendix 2
See Fig. 2.
Fig. 2 Histograms for the
assessment of potential floor
and ceiling effects in the three
SSM subscales at a baseline and
b 6 months. X-axis of all
histograms shows the range of
values for the SSM subscales;
on the y-axis the frequency of
observed values is depicted
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Appendix 3
See Table 4.
Appendix 4
See Fig. 3.
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